Arş. Gör. EMRE YAŞAR

Yayın Ağı

Makaleler 20

1. Ferric Carboxymaltose reduces NT-proBNP and enhances functional status in chronic kidney disease and heart failure with preserved ejection fraction La carboximaltosa férrica reduce el NT-proBNP y mejora el estado funcional en la enfermedad renal crónica y la insuficiencia cardíaca con fracción de eyección preservada

HELVACI Ö., YILDIRIM S., YAŞAR E., DEMİREZEN A., AKÇAY Ö. F., ALTOK K., et al.

Revista de Nefrologia, Dialisis y Trasplante , cilt.45, sa.3, ss.146-152, 2025 (SCI-Expanded, Scopus)

2. Ferric Carboxymaltose reduces NT-proBNP and enhances functional status in chronic kidney disease and heart failure with preserved ejection fraction

HELVACI Ö., Yildirim S., Yasar E., DEMİREZEN A., AKÇAY Ö. F., ALTOK K., et al.

REVISTA DE NEFROLOGIA DIALISIS Y TRASPLANTE , cilt.45, sa.3, ss.146-152, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

3. Resting energy expenditure: Is there any difference between dialysis and non-dialysis dependent chronic kidney disease patients?

Yasar E., TEK N., TEKBUDAK M. Y., Yurtdas-Depboylu G., Deveci-Bulut T. S., Ozbas B., et al.

MEDITERRANEAN JOURNAL OF NUTRITION AND METABOLISM , cilt.18, sa.1, ss.20-26, 2025 (ESCI, Scopus) Sürdürülebilir Kalkınma

4. Evaluation of the short and long-term effects of ferric carboxymaltose on phosphorus and parathyroid hormone levels in patients with CKD Evaluación de los efectos a corto y largo plazo de la carboximaltosa férrica sobre los niveles de fósforo y hormona paratiroidea en pacientes con enfermedad renal crónica

HELVACI Ö., YILDIRIM S., YAŞAR E., Tuzcu B., Işıl Ay E., Cavnar Helvacı B., et al.

Revista Colombiana de Nefrologia , cilt.12, sa.1, 2025 (Scopus)

5. Characteristics and Outcomes of Critically Ill Medical Patients with Invasive Mechanical Ventilation: A Retrospective Cohort Study

Yasar E., İNCİ K., AYGENCEL BIKMAZ Ş. G., TÜRKOĞLU M.

JOURNAL OF CRITICAL & INTENSIVE CARE , cilt.15, sa.3, ss.102-109, 2024 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma

6. Heterologous Versus Homologous COVID-19 Boosters: Immune Response Outcomes in Renal Transplant Recipients

YILDIZ Y., YAŞAR E., ÖZTÜRK E., KARAKAN M. Ş., HELVACI Ö., ÖZGER H. S., et al.

Journal of Medical Virology , cilt.96, sa.11, 2024 (SCI-Expanded, Scopus)

7. Comparison of homologous and heterologous inactivated and mRNA vaccination programme against SARS-CoV-2 in dialysis patients

YAŞAR E., YILDIZ Y., ÖZTÜRK E., Gok Oguz E., Coskun Yenigun E., Ozturk R., et al.

Nephrology , cilt.29, sa.7, ss.405-414, 2024 (SCI-Expanded, Scopus)

8. Could mesangial C3 deposition be an independent prognostic marker in immunoglobulin A nephropathy?

Cetinkaya H., GÜRSU M., Yazici H., Cebeci E., EREN N., ALTIPARMAK M. R., et al.

Journal of Nephrology , cilt.37, sa.4, ss.923-932, 2024 (SCI-Expanded, Scopus)

9. Diagnostic accuracy of venous system ultrasound for subtypes of acute kidney injury

Aslaner M. A., Helvacı Ö., Haycock K., Kılıçaslan İ., Yaşar E., Cerit M. N., et al.

EMERGENCY MEDICINE JOURNAL , cilt.41, sa.5, ss.304-310, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

10. Association of Serum Adropin Levels with Nutritional Status and Lipid Profile in Patients with Kidney Failure with Replacement Therapy

Depboylu G. Y., TEK N., Gunes B. D., Celik O. M., Uyar G. O., BAYAZIT A. D., et al.

GALICIAN MEDICAL JOURNAL , cilt.30, sa.4, 2023 (ESCI)

11. Familial Mediterranean Fever-Related Amyloidosis in Turkey: A Need for a Familial Mediterranean Fever Registry

HELVACI Ö., YAŞAR E.

Experimental and Clinical Transplantation , cilt.21, ss.101-104, 2023 (SCI-Expanded, Scopus)

12. Impact of HLA polymorphisms on the susceptibility to SARS-CoV-2 infection and related mortality in patients with renal replacement therapy

AKÇAY Ö. F., Yeter H. H., ÜNSAL Y., YAŞAR E., GÖNEN S., DERİCİ Ü.

HUMAN IMMUNOLOGY , cilt.84, sa.4, ss.272-277, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

13. Relationship between Health Literacy and Frailty in Older Adults with Chronic Kidney Disease

Candemir B., YILDIRIM BORAZAN F., Yasar E., Erten Y., GÖKER B.

EXPERIMENTAL AGING RESEARCH , cilt.49, sa.3, ss.201-213, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

14. The Relationship Between Myostatin, Inflammatory Markers, and Sarcopenia in Patients With Chronic Kidney Disease

YAŞAR E., Tek N., TEKBUDAK M. Y., Yurtdaş G., GÜLBAHAR Ö., Uyar G. Ö., et al.

Journal of Renal Nutrition , cilt.32, sa.6, ss.677-684, 2022 (SCI-Expanded, Scopus)

15. ACCURACY OF MULTI-ORGAN POINT-OF-CARE ULTRASOUND FOR ACUTE KIDNEY INJURY ETIOLOGIES

Aslaner M. A., Yaşar E., Kılıçaslan İ., Cerit M. N., Emren S. V., Yüksek B., et al.

ULTRASOUND IN MEDICINE AND BIOLOGY , cilt.48, sa.10, ss.2009-2018, 2022 (SCI-Expanded, Scopus)

16. Compliance of NKF KDOQI 2020 nutrition guideline recommendations with other guideline recommendations and protein energy wasting criteria in hemodialysis patients

Bingol F., YILDIRAN H., ERTEN Y., YAŞAR E.

Nephrologie et Therapeutique , cilt.18, sa.4, ss.217-221, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

17. Could urinary kidney injury molecule-1 be a good marker in subclinical acute kidney injury in mild to moderate COVID-19 infection?

YAŞAR E., ÖZGER H. S., YETER H. H., YILDIRIM Ç., OSMANOV Z., ÇETİN T. E., et al.

INTERNATIONAL UROLOGY AND NEPHROLOGY , cilt.54, sa.3, ss.627-636, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

18. Early predictors of acute kidney injury in COVID-19 patients

YILDIRIM Ç., ÖZGER H. S., YAŞAR E., Tombul N., GÜLBAHAR Ö., YILDIZ M., et al.

NEPHROLOGY , cilt.26, sa.6, ss.513-521, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

19. The reliability and success of peritoneal dialysis during the COVID-19 pandemic

Yeter H. H., Gok Oguz E., Akcay O. F., Karaer R., YAŞAR E., Duranay M., et al.

SEMINARS IN DIALYSIS , cilt.34, sa.2, ss.147-156, 2021 (SCI-Expanded, Scopus)

20. Demographic, clinical and laboratory characteristics of rapidly progressive glomerulonephritis in Turkey: Turkish Society of Nephrology-Glomerular Diseases (TSN-GOLD) Working Group

Aydin Z., TÜRKMEN K., Dede F., YAŞAR E., Ozturk S., Aydin M., et al.

CLINICAL AND EXPERIMENTAL NEPHROLOGY , cilt.25, sa.2, ss.173-183, 2021 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 4

1. Evaluation of the effect of IV iron therapy on eGFR and Pro-BNP in patients with chronic kidney disease and heart failure with preserved EF

HELVACI Ö., SEZENÖZ B., AY E. I., YILDIRIM S., YAŞAR E., SEÇKİN GÖBÜT Ö., et al.

61st Congress of European-Renal-Association (ERA), Stockholm, İsveç, 23 - 26 Mayıs 2024, (Özet Bildiri)

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Proje

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları